Table 2.
Study periods | Screening | Randomisation | Discharge from ER | Discharge from the acute setting | Day 30 | Day 90 | Reference diagnosis |
Visit | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
Time (hour, day) | hr0 | hr2* | hr6* | dx | d30 | d90 | |
Demographics | x | ||||||
Medical history | x | ||||||
Inclusion/exclusion criteria | x | ||||||
Physical examination | x | ||||||
Vital signs | x | ||||||
Laboratory tests | x | x | |||||
CXR, LDCT, LUS | x | ||||||
Main diagnosis before ER discharge | x | x | |||||
Other diagnosis outcomes | x | x | x | ||||
Number of antibiotic free days | x | ||||||
Clinical, safety and cost outcomes | x | x | |||||
Readmission and mortality | x | x | |||||
QoL questionnaire | x | x | x | ||||
Panel of experts | x |
*Approximately.
CXR, chest x-ray; d, day; ER, emergency room; hr, hour; LDCT, low-dose CT; LUS, lung ultrasonography; QoL, quality of life.